Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.16), $0.10 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $903 thousand versus the consensus estimate of $1.66 million.

For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.